🔎 Trials Near Me

Home › Lung Cancer › Vermont

Lung Cancer clinical trials in Vermont

7 studies for Lung Cancer are looking for participants at sites in Vermont.

Cities in Vermont

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Dartmouth Cancer Center - North, Saint Johnsbury
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT04267848

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  • Dartmouth Cancer Center - North, Saint Johnsbury
  • White River Junction Veteran Administration Medical Center, White River Junction
RecruitingPhase 3
Ages 70 and older · All sexes · Updated Sep 24, 2026 · NCT06096844

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • The University of Vermont Medical Center Inc., Burlington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

  • Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
  • University of Vermont Medical Center, Burlington
  • University of Vermont and State Agricultural College, Burlington
  • and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05624996

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
  • University of Vermont Medical Center, Burlington
  • University of Vermont and State Agricultural College, Burlington
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 3, 2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • Dartmouth Cancer Center - North, Saint Johnsbury
  • White River Junction Veteran Administration Medical Center, White River Junction
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated May 5, 2026 · NCT06616584

Accelerated Pulmonary Rehabilitation in the Preoperative Period

  • University of Vermont Medical Center, Burlington
Recruiting
Ages 18 and older · All sexes · Updated Mar 23, 2026 · NCT06432972

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.